Cover Image
市場調查報告書

Quest PharmaTech Inc.的產品平台分析

Quest PharmaTech Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253716
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Quest PharmaTech Inc.的產品平台分析 Quest PharmaTech Inc. - Product Pipeline Review - 2015
出版日期: 2015年10月14日 內容資訊: 英文 33 Pages
簡介

Quest PharmaTech Inc.ha是開發綜合化療和免疫療法之抗體癌症治療藥的生物科技企業。

本報告提供Quest PharmaTech Inc.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Quest PharmaTech Inc.的基本資料

Quest PharmaTech Inc.概要

  • 主要資訊
  • 企業資料

Quest PharmaTech Inc.:R&D概要

  • 主要的治療範圍

Quest PharmaTech Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Quest PharmaTech Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Quest PharmaTech Inc.:藥物簡介

  • oregovomab
  • AR-20.5
  • SL-052
  • 阻礙前列腺癌用的PSA單株抗體
  • MUC1為目標的單株抗體

Quest PharmaTech Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Quest PharmaTech Inc.:最近的開發平台趨勢

Quest PharmaTech Inc.:暫停中的計劃

Quest PharmaTech Inc.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • ACP-2127
    • oregovomab

Quest PharmaTech Inc.:總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07659CDB

Summary

Global Markets Direct's, 'Quest PharmaTech Inc. - Product Pipeline Review - 2015', provides an overview of the Quest PharmaTech Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Quest PharmaTech Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Quest PharmaTech Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Quest PharmaTech Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Quest PharmaTech Inc.'s pipeline products

Reasons to buy

  • Evaluate Quest PharmaTech Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Quest PharmaTech Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Quest PharmaTech Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Quest PharmaTech Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Quest PharmaTech Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Quest PharmaTech Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents 2
  • List of Tables 4
  • List of Figures 4
  • Quest PharmaTech Inc. Snapshot 5
  • Quest PharmaTech Inc. Overview 5
  • Key Information 5
  • Key Facts 5
  • Quest PharmaTech Inc. - Research and Development Overview 6
  • Key Therapeutic Areas 6
  • Quest PharmaTech Inc. - Pipeline Review 8
  • Pipeline Products by Stage of Development 8
  • Pipeline Products - Monotherapy 9
  • Pipeline Products - Partnered Products 10
  • Partnered Products/Combination Treatment Modalities 11
  • Quest PharmaTech Inc. - Pipeline Products Glance 12
  • Quest PharmaTech Inc. - Clinical Stage Pipeline Products 12
  • Phase II Products/Combination Treatment Modalities 12
  • Phase I Products/Combination Treatment Modalities 13
  • Quest PharmaTech Inc. - Early Stage Pipeline Products 14
  • Preclinical Products/Combination Treatment Modalities 14
  • Quest PharmaTech Inc. - Drug Profiles 15
  • oregovomab 15
  • Product Description 15
  • Mechanism of Action 15
  • R&D Progress 15
  • SL-052 18
  • Product Description 18
  • Mechanism of Action 18
  • R&D Progress 18
  • AR-20.5 20
  • Product Description 20
  • Mechanism of Action 20
  • R&D Progress 20
  • Monoclonal Antibody To Target MUC1 for Oncology 21
  • Product Description 21
  • Mechanism of Action 21
  • R&D Progress 21
  • Monoclonal Antibody to Antagonize HER2/neu for Breast Cancer 22
  • Product Description 22
  • Mechanism of Action 22
  • R&D Progress 22
  • Monoclonal Antibody to Inhibit PSA for Prostate Cancer 23
  • Product Description 23
  • Mechanism of Action 23
  • R&D Progress 23
  • Quest PharmaTech Inc. - Pipeline Analysis 24
  • Quest PharmaTech Inc. - Pipeline Products by Target 24
  • Quest PharmaTech Inc. - Pipeline Products by Route of Administration 25
  • Quest PharmaTech Inc. - Pipeline Products by Molecule Type 26
  • Quest PharmaTech Inc. - Pipeline Products by Mechanism of Action 27
  • Quest PharmaTech Inc. - Recent Pipeline Updates 28
  • Quest PharmaTech Inc. - Discontinued Pipeline Products 30
  • Discontinued Pipeline Product Profiles 30
  • ACP-2127 30
  • oregovomab 30
  • Quest PharmaTech Inc. - Locations And Subsidiaries 31
  • Head Office 31
  • Appendix 32
  • Methodology 32
  • Coverage 32
  • Secondary Research 32
  • Primary Research 32
  • Expert Panel Validation 32
  • Contact Us 32
  • Disclaimer 33

List of Tables

  • Quest PharmaTech Inc., Key Information 5
  • Quest PharmaTech Inc., Key Facts 5
  • Quest PharmaTech Inc. - Pipeline by Indication, 2015 7
  • Quest PharmaTech Inc. - Pipeline by Stage of Development, 2015 8
  • Quest PharmaTech Inc. - Monotherapy Products in Pipeline, 2015 9
  • Quest PharmaTech Inc. - Partnered Products in Pipeline, 2015 10
  • Quest PharmaTech Inc. - Partnered Products/ Combination Treatment Modalities, 2015 11
  • Quest PharmaTech Inc. - Phase II, 2015 12
  • Quest PharmaTech Inc. - Phase I, 2015 13
  • Quest PharmaTech Inc. - Preclinical, 2015 14
  • Quest PharmaTech Inc. - Pipeline by Target, 2015 24
  • Quest PharmaTech Inc. - Pipeline by Route of Administration, 2015 25
  • Quest PharmaTech Inc. - Pipeline by Molecule Type, 2015 26
  • Quest PharmaTech Inc. - Pipeline Products by Mechanism of Action, 2015 27
  • Quest PharmaTech Inc. - Recent Pipeline Updates, 2015 28
  • Quest PharmaTech Inc. - Discontinued Pipeline Products, 2015 30

List of Figures

  • Quest PharmaTech Inc. - Pipeline by Top 10 Indication, 2015 7
  • Quest PharmaTech Inc. - Pipeline by Stage of Development, 2015 8
  • Quest PharmaTech Inc. - Monotherapy Products in Pipeline, 2015 9
  • Quest PharmaTech Inc. - Partnered Products in Pipeline, 2015 10
  • Quest PharmaTech Inc. - Pipeline by Top 10 Target, 2015 24
  • Quest PharmaTech Inc. - Pipeline by Top 10 Route of Administration, 2015 25
  • Quest PharmaTech Inc. - Pipeline by Top 10 Molecule Type, 2015 26
  • Quest PharmaTech Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 27
Back to Top